OHSU Doernbecher is first hospital in Pacific Northwest to offer new FDA-approved treatment for advanced leukemia

Kymriah, first gene transfer therapy in the U.S., now available for children and young adults with ALL

By Tracy Brawley and Amanda Gibbs September 21, 2017 Portland, Oregon

Eneida Nemecek, M.D., M.S., M.B.A., (third from right) and the OHSU Doernbecher CAR-T cell therapy team. (OHSU)

Eneida Nemecek, M.D., M.S., M.B.A., director of the pediatric bone marrow transplantation program at OHSU Doernbecher Children’s Hospital. (OHSU)

OHSU Doernbecher Children’s Hospital. (OHSU/Fritz Liedtke)

OHSU Doernbecher pediatric bone marrow transplant team led by (center front) Eneida Nemecek, M.D., M.S., M.B.A. (OHSU)